News Conference News AHA 2016 Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients Yael L. Maxwell November 13, 2016
News Daily News New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients Michael O'Riordan November 13, 2016
News Daily News High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients Michael O'Riordan November 10, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Daily News MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga Michael O'Riordan November 09, 2016
News Conference News TCT 2016 Novel SES Fails to Match Xience EES for Chronic Total Occlusions Yael L. Maxwell November 08, 2016
News Conference News TCT 2016 ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions L.A. McKeown November 07, 2016
News Conference News Watchman, Amulet LAA Closure Devices Carry Low Complication Rates Todd Neale November 04, 2016
News Industry News Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 November 03, 2016
Presentation TCT 2016 ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs an Uncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries Presenter: Martin B. Leon, Louis A. Cannon, Sean P. Lyden November 02, 2016
Presentation TCT 2016 What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond? Presenter: John D. Carroll, Christian Spies November 01, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016
Presentation TCT 2016 PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen November 01, 2016
Presentation TCT 2016 SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Presenter: Gregg W. Stone, Philippe Pibarot, Susheel K. Kodali November 01, 2016
Presentation TCT 2016 Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples) Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber November 01, 2016
Presentation TCT 2016 TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials Presenter: Antonio L. Bartorelli, Kenneth Chin, Ariel Furer October 31, 2016
News Industry News TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies October 31, 2016
Presentation TCT 2016 TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A Pooled Patient Level Analysis From 17 Randomized Trials Presenter: Sorin J. Brener, Jean-François Tanguay, Jaya Chandrasekhar October 31, 2016
News Conference News TCT 2016 ‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent Todd Neale October 31, 2016